Pages with the most revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #1 to #50.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Breast cancer (1,452 revisions)
- Multiple myeloma (1,251 revisions)
- Non-small cell lung cancer (1,164 revisions)
- Follicular lymphoma (976 revisions)
- Drug index (954 revisions)
- Chronic lymphocytic leukemia (910 revisions)
- Acute myeloid leukemia (867 revisions)
- Diffuse large B-cell lymphoma (832 revisions)
- Colon cancer (816 revisions)
- Hodgkin lymphoma (801 revisions)
- Prostate cancer (670 revisions)
- Mantle cell lymphoma (638 revisions)
- Esophageal cancer (610 revisions)
- Ovarian cancer (583 revisions)
- B-cell acute lymphoblastic leukemia (575 revisions)
- Bladder cancer (552 revisions)
- Melanoma (534 revisions)
- Gastric cancer (504 revisions)
- Renal cell carcinoma (491 revisions)
- Breast cancer, HER2-positive (472 revisions)
- Small cell lung cancer (439 revisions)
- Head and neck cancer (430 revisions)
- Pancreatic cancer (422 revisions)
- Diffuse large B-cell lymphoma - historical (421 revisions)
- Chronic myelogenous leukemia (404 revisions)
- Multiple myeloma - historical (373 revisions)
- Breast cancer, ER-positive (368 revisions)
- Soft tissue sarcoma (345 revisions)
- Acute promyelocytic leukemia (333 revisions)
- Hepatocellular carcinoma (332 revisions)
- CNS lymphoma (324 revisions)
- Waldenström macroglobulinemia (323 revisions)
- Breast cancer - historical (312 revisions)
- Multiple myeloma, relapsed-refractory (308 revisions)
- Main Page (303 revisions)
- Marginal zone lymphoma (299 revisions)
- Cervical cancer (295 revisions)
- Complex multipart regimens (288 revisions)
- Light-chain (AL) amyloidosis (262 revisions)
- B-cell acute lymphoblastic leukemia, pediatric (262 revisions)
- Endometrial cancer (256 revisions)
- Rectal cancer (245 revisions)
- Myelodysplastic syndrome (243 revisions)
- Peripheral T-cell lymphoma (238 revisions)
- Multiple myeloma, induction (236 revisions)
- Glioblastoma (228 revisions)
- Autologous HSCT (223 revisions)
- Anaplastic glioma (221 revisions)
- Non-small cell lung cancer, EGFR-mutated (220 revisions)
- Breast cancer, triple negative (216 revisions)